作为疫情安全威胁的不公平犯罪化
Nataliya Gutorova1, Oleksii Soloviov2, Yevhen Gnedik3
1Yaroslav Mudryi National Law University , Kharkiv, Ukraine.
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
|February 14, 2025
概括
刑事法律阻碍了传染病控制. 根据医学证据,对艾滋病毒/艾滋病,结核病和性传播疾病等不那么危险的疾病的传播进行非刑事化,对于有效的公共卫生战略至关重要.
科学领域:
- 公共卫生法 公共卫生法
- 传染病流行病学 传染病流行病学
- 刑事司法 刑事司法 刑事司法
背景情况:
- 刑法对传染病预防和治疗的影响往往是负面的.
- 特别关注艾滋病毒/艾滋病,结核病和性传播疾病.
研究的目的:
- 提高人们对刑事法律对公共健康的有害影响的认识.
- 激发关于改革传染病法律法规的讨论.
主要方法:
- 来自UNAIDS,世卫组织和法律来源的经验和分析数据的分析.
- 审查来自乌克兰,德国,爱沙尼亚,立陶宛和波兰的法律行为和法院判决.
- 应用分析,比较,合成,系统,社会学,诱导和推断研究方法.
主要成果:
- 刑事法规可能会阻碍传染病的有效预防和治疗.
- 分析了几个欧洲国家的法律框架.
- 审查了21项法律和26项法院判决.
结论:
- 刑法必须与当前的医学研究成果保持一致.
- 对于不构成严重危险的疾病或当感染没有无意发生时,非刑事化是必要的.
- 坚持民主社会的必要性原则对于规范传染病传播至关重要.
更多相关视频
07:13Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
Published on: April 9, 2021
4.2K
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
1.8K
相关概念视频
Confounding in Epidemiological Studies
128
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
128
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
136
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
136
Bias in Epidemiological Studies
137
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
137
Steps in Outbreak Investigation
102
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
102
Pharmacovigilance
768
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
768
